SEARCH

SEARCH BY CITATION

REFERENCES

  • Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, van Os J, Ibanez MI, Ruiperez MA, Ortet G, et al. 2009. Early adversity and 5-HTT/BDNF genes: New evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 39(9): 14251432.
  • Alexopoulos GS, Schultz SK, Lebowitz BD. 2005. Late-life depression: A model for medical classification. Biol Psychiatry 58(4): 283289.
  • Amano K, Yamada K, Iwayama Y, Detera-Wadleigh SD, Hattori E, Toyota T, Tokunaga K, Yoshikawa T, Yamakawa K. 2008. Association study between the Down syndrome cell adhesion molecule (DSCAM) gene and bipolar disorder. Psychiatr Genet 18(1): 110.
  • Arai M, Itokawa M, Yamada K, Toyota T, Arai M, Haga S, Ujike H, Sora I, Ikeda K, Yoshikawa T. 2004. Association of neural cell adhesion molecule 1 gene polymorphisms with bipolar affective disorder in Japanese individuals. Biol Psychiatry 55(8): 804810.
  • Arranz MJ, Erdmann J, Kirov G, Rietschel M, Sodhi M, Albus M, Ball D, Maier W, Davies N, Franzek E, et al. 1997. 5-HT2A receptor and bipolar affective disorder: Association studies in affected patients. Neurosci Lett 224(2): 9598.
  • Aston C, Jiang L, Sokolov BP. 2005. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10(3): 309322.
  • Atz ME, Rollins B, Vawter MP. 2007. NCAM1 association study of bipolar disorder and schizophrenia: Polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr Genet 17(2): 5567.
  • Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen-White KR, Rosso A, Donald JA, Adams LJ, Schofield PR. 2002. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatry 7(8): 851859.
  • Bailer U, Leisch F, Meszaros K, Lenzinger E, Willinger U, Strobl R, Heiden A, Gebhardt C, Doge E, Fuchs K, et al. 2002. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatry 52(1): 4052.
  • Bauer M, Grof P, Rasgon N, Bschor T, Glenn T, Whybrow PC. 2006. Temporal relation between sleep and mood in patients with bipolar disorder. Bipolar Disord 8(2): 160167.
  • Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13(2): 197207.
  • Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V, Wetsel WC, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2008a. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132(1): 125136.
  • Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC, Gainetdinov RR, Caron MG. 2008b. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105(4): 13331338.
  • Begemann M, Sargin D, Rossner MJ, Bartels C, Theis F, Wichert SP, Stender N, Fischer B, Sperling S, Stawicki S, et al. 2008. Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Mol Med 14(9–10): 546552.
  • Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, Smeraldi E. 2004. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355(1–2): 3740.
  • Benes FM, Matzilevich D, Burke RE, Walsh J. 2006. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 11(3): 241251.
  • Bertram I, Bernstein HG, Lendeckel U, Bukowska A, Dobrowolny H, Keilhoff G, Kanakis D, Mawrin C, Bielau H, Falkai P, et al. 2007. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. Ann NY Acad Sci 1096: 147156.
  • Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle MC. 2002. Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: The case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry 51(9): 762765.
  • Brezo J, Bureau A, Merette C, Jomphe V, Barker ED, Vitaro F, Hebert M, Carbonneau R, Tremblay RE, Turecki G. 2009. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: A 22-year longitudinal gene-environment study. Mol Psychiatry. [Epub ahead of print]
  • Bunney WE, Bunney BG. 2000. Molecular clock genes in man and lower animals: Possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22(4): 335345.
  • Chagnon YC, Merette C, Bouchard RH, Emond C, Roy MA, Maziade M. 2004. A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses. Mol Psychiatry 9(12): 10671074.
  • Chambers JS, Perrone-Bizzozero NI. 2004. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem Res 29(12): 22932302.
  • Chao HM, Kao HT, Porton B. 2008. BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet Part B 147B(4): 505506.
  • Chee IS, Lee SW, Kim JL, Wang SK, Shin YO, Shin SC, Lee YH, Hwang HM, Lim MR. 2001. 5-HT2A receptor gene promoter polymorphism-1438A/G and bipolar disorder. Psychiatr Genet 11(3): 111114.
  • Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R, Sharpe L, Kanyas K, Lerer B, Lilliston B, et al. 2006. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 11(3): 252260.
  • Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, et al. 2005. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 102(43): 1565315658.
  • Cichon S, Schmidt-Wolf G, Schumacher J, Muller DJ, Hurter M, Schulze TG, Albus M, Borrmann-Hassenbach M, Franzek E, Lanczik M, et al. 2001. A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25–q26. Mol Psychiatry 6(3): 342349.
  • Clamp M, Fry B, Kamal M, Xie X, Cuff J, Lin MF, Kellis M, Lindblad-Toh K, Lander ES. 2007. Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci USA 104(49): 1942819433.
  • Curtis D, Kalsi G, Brynjolfsson J, McInnis M, O'Neill J, Smyth C, Moloney E, Murphy P, McQuillin A, Petursson H, et al. 2003. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 13(2): 7784.
  • Degnan JH, Lasky-Su J, Raby BA, Xu M, Molony C, Schadt EE, Lange C. 2008. Genomics and genome-wide association studies: An integrative approach to expression QTL mapping. Genomics
  • Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, Rollins DY, Moses T, Sanders AR, Karkera JD, et al. 1999. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 96(10): 56045609.
  • Etain B, Mathieu F, Rietschel M, Maier W, Albus M, McKeon P, Roche S, Kealey C, Blackwood D, Muir W, et al. 2006. Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: Supportive evidence for linkage at 3p14. Mol Psychiatry 11(7): 685694.
  • Ewald H, Flint T, Kruse TA, Mors O. 2002. A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22-21, 4p16, 6q14-22, 10q26 and 16p13.3. Mol Psychiatry 7(7): 734744.
  • Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D, Liang KY, Pulver AE. 2004. Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am J Hum Genet 75(2): 204219.
  • Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, et al. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6): 918936.
  • Fan J, Sklar P. 2008. Genetics of bipolar disorder: Focus on BDNF Val66Met polymorphism. Novartis Found Symp 289: 6072, discussion 72–73, 87–93.
  • Fatemi SH, Reutiman TJ, Folsom TD, Lee S. 2008. Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder. Psychiatr Genet 18(6): 282288.
  • Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al. 2008a. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9): 10561058.
  • Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al. 2008b. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet
  • Franken P, Lopez-Molina L, Marcacci L, Schibler U, Tafti M. 2000. The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity. J Neurosci 20(2): 617625.
  • Freimer NB, Reus VI, Escamilla MA, McInnes LA, Spesny M, Leon P, Service SK, Smith LB, Silva S, Rojas E, et al. 1996. Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet 12(4): 436441.
  • Georgieva L, Dimitrova A, Ivanov D, Nikolov I, Williams NM, Grozeva D, Zaharieva I, Toncheva D, Owen MJ, Kirov G, et al. 2008. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry. 64(5): 419427.
  • Green EK, Raybould R, Macgregor S, Gordon-Smith K, Heron J, Hyde S, Grozeva D, Hamshere M, Williams N, Owen MJ, et al. 2005. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 62(6): 642648.
  • Harauz G, Ladizhansky V, Boggs JM. 2009. Structural polymorphism and multifunctionality of myelin basic protein. Biochemistry 48(34): 80948104.
  • Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. 2006. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry. 60(2): 93105.
  • Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, Tankou S, et al. 2007. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 104(36): 1450114506.
  • Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, Malhotra AK. 2004. Disrupted in schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 75(5): 862872.
  • Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. 2004. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9(4): 406416.
  • Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppa T, Lichtermann D, Praschak-Rieder N, Neumeister A, Nilsson LG, et al. 2003. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28(4): 734739.
  • Johnson C, Drgon T, McMahon FJ, Uhl GR. 2009. Convergent genome wide association results for bipolar disorder and substance dependence. Am J Med Genet Part B 150B(2): 182190.
  • Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, Mohammed A, Pham Q, Laeng P, Brockman JA, et al. 2004. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 138(1–2): 173188.
  • Kalman J, Palotas A, Juhasz A, Rimanoczy A, Hugyecz M, Kovacs Z, Galsi G, Szabo Z, Pakaski M, Feher LZ, et al. 2005. Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression—Evolution of antidepressants and the role of the “neuro-immune” system. Neurochem Res 30(11): 14291438.
  • Karege F, Schwald M, El Kouaissi R. 2004. Drug-induced decrease of protein kinase a activity reveals alteration in BDNF expression of bipolar affective disorder. Neuropsychopharmacology 29(4): 805812.
  • Kelsoe JR, Niculescu AB III. 2002. Finding genes for bipolar disorder in the functional genomics era: From convergent functional genomics to phenomics and back. CNS Spectr 7(3): 215226.
  • Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA, Flodman P, Khristich J, Mroczkowski-Parker Z, Brown JL, et al. 2001. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 98(2): 585590.
  • Kerner B, Jasinska AJ, Deyoung J, Almonte M, Choi OW, Freimer NB. 2009. Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 150B(1): 2432.
  • Kim S, Choi KH, Baykiz AF, Gershenfeld HK. 2007. Suicide candidate genes associated with bipolar disorder and schizophrenia: An exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 8(1): 413.
  • Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, Ffrench-Mullen J, Turecki G. 2009. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry. 14(2): 175189.
  • Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. 2004. Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9(6): 609620 544.
  • Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, et al. 2009. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry. [Epub ahead of print]
  • Lachman HM, Stopkova P, Papolos DF, Pedrosa E, Margolis B, Aghalar MR, Saito T. 2006. Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder. Neuropsychobiology 53(2): 5762.
  • Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T, Papolos DF, Stopkova P. 2007. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet Part B 144B(3): 259265.
  • Lahiri DK, Maloney B, Zawia NH. 2009. The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 14(11): 9921003.
  • Lambert D, Middle F, Hamshere ML, Segurado R, Raybould R, Corvin A, Green E, O'Mahony E, Nikolov I, Mulcahy T, et al. 2005. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: Evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Mol Psychiatry 10(9): 831841.
  • Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE, Edenberg HJ, Kuczenski R, Geyer MA, Nurnberger JI Jr, et al. 2007a. Towards understanding the schizophrenia code: An expanded convergent functional genomics approach. Am J Med Genet Part B 144B(2): 129158.
  • Le-Niculescu H, McFarland MJ, Mamidipalli S, Ogden CA, Kuczenski R, Kurian SM, Salomon DR, Tsuang MT, Nurnberger JI Jr, Niculescu AB. 2007b. Convergent functional genomics of bipolar disorder: From animal model pharmacogenomics to human genetics and biomarkers. Neurosci Biobehav Rev 31(6): 897903.
  • Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, Rodd ZA, Paulus M, Geyer MA, Edenberg HJ, et al. 2008. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet Part B 147B(2): 134166.
  • Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, Tsuang MT, Salomon DR, Nurnberger JI Jr, Niculescu AB. 2009a. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 14(2): 156174.
  • Le-Niculescu H, Patel SD, Bhat M, Kuczenski R, Faraone SV, Tsuang MT, McMahon FJ, Schork NJ, Nurnberger JI Jr, Niculescu AB III. 2009b. Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet Part B 150B(2): 155181.
  • Lenox RH, Gould TD, Manji HK. 2002. Endophenotypes in bipolar disorder. Am J Med Genet 114(4): 391406.
  • Levinson DF, Evgrafov OV, Knowles JA, Potash JB, Weissman MM, Scheftner WA, Depaulo JR Jr, Crowe RR, Murphy-Eberenz K, Marta DH, et al. 2007. Genetics of recurrent early-onset major depression (GenRED): Significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. Am J Psychiatry 164(2): 259264.
  • Lewohl JM, Wixey J, Harper CG, Dodd PR. 2005. Expression of MBP, PLP, MAG, CNP, and GFAP in the human alcoholic brain. Alcohol Clin Exp Res 29(9): 16981705.
  • Licinio J, Dong C, Wong ML. 2009. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 66(5): 488497.
  • Lin YM, Yang HC, Lai TJ, Fann CS, Sun HS. 2003. Receptor mediated effect of serotonergic transmission in patients with bipolar affective disorder. J Med Genet 40(10): 781786.
  • Liu L, Foroud T, Xuei X, Berrettini W, Byerley W, Coryell W, El-Mallakh R, Gershon ES, Kelsoe JR, Lawson WB, et al. 2008. Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder. Psychiatr Genet 18(6): 267274.
  • Macgregor S, Visscher PM, Knott SA, Thomson P, Porteous DJ, Millar JK, Devon RS, Blackwood D, Muir WJ. 2004. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry 9(12): 10831090.
  • Maeda K, Nwulia E, Chang J, Balkissoon R, Ishizuka K, Chen H, Zandi P, McInnis MG, Sawa A. 2006. Differential expression of disrupted-in-schizophrenia (DISC1) in bipolar disorder. Biol Psychiatry 60(9): 929935.
  • Magnusson A, Partonen T. 2005. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr 10(8): 625634, quiz 1–14.
  • Mansour HA, Wood J, Logue T, Chowdari KV, Dayal M, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL. 2006. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 5(2): 150157.
  • Matigian N, Windus L, Smith H, Filippich C, Pantelis C, McGrath J, Mowry B, Hayward N. 2007. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry. 12(9): 815825.
  • Maziade M, Roy MA, Chagnon YC, Cliche D, Fournier JP, Montgrain N, Dion C, Lavallee JC, Garneau Y, Gingras N, et al. 2005. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: A dense genome scan in Eastern Quebec families. Mol Psychiatry 10(5): 486499.
  • McAuley EZ, Fullerton JM, Blair IP, Donald JA, Mitchell PB, Schofield PR. 2009. Association between the serotonin 2A receptor gene and bipolar affective disorder in an Australian cohort. Psychiatr Genet. 9(5): 244252.
  • McClung CA. 2007. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 114(2): 222232.
  • McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, Biederman J, Mick E, Faraone SV, Niculescu AB, et al. 2009. Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry 9: 70.
  • McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, Rojas E, Spesny M, Baharloo S, Blankenship K, et al. 1996. A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci USA 93(23): 1306013065.
  • Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M, Diab H, Morley CP, Medeiros H, Macedo A, et al. 2005. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet Part B 136B(1): 1225.
  • Millar JK, Mackie S, Clapcote SJ, Murdoch H, Pickard BS, Christie S, Muir WJ, Blackwood DH, Roder JC, Houslay MD, et al. 2007. Disrupted in schizophrenia 1 and phosphodiesterase 4B: Towards an understanding of psychiatric illness. J Physiol 584(Pt 2): 401405.
  • Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B, Laprise C, Bouchard G, Plante M, Gobeil L, et al. 1999. Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 88(5): 567587.
  • Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I, Kato T, Osumi N, Higuchi T, Niwa S, et al. 2006. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: Relevance to neuronal network perturbation. Hum Mol Genet 15(12): 19491962.
  • Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study. Am J Hum Genet 71(3): 651655.
  • Niculescu AB III. 2006. Polypharmacy in oligopopulations: What psychiatric genetics can teach biological psychiatry. Psychiatr Genet 16(6): 241244.
  • Niculescu AB III, Kelsoe JR. 2001. Convergent functional genomics: Application to bipolar disorder. Ann Med 33(4): 263271.
  • Niculescu AB, Le-Niculescu H. 2010. Convergent functional genomics: What we have learned and can learn about genes, pathways, and mechanisms. Neuropsychopharmacology 35(1): 355356.
  • Niculescu A, Segal D, Kuczenski R, Barrett T, Hauger R, Kelsoe J. 2000a. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach. Physiol Genomics 4(1): 8391.
  • Niculescu AB III, Segal DS, Kuczenski R, Barrett T, Hauger RL, Kelsoe JR. 2000b. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach. Physiol Genomics 4(1): 8391.
  • Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ, Caligiuri MP, Lohr JB. 2006. PhenoChipping of psychotic disorders: A novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet Part B 141B(6): 653662.
  • Niculescu AB III, Schork NJ, Salomon DR. 2009. Mindscape: A convergent perspective on life, mind, consciousness and happiness. J Affect Disord
  • Nievergelt CM, Kripke DF, Barrett TB, Burg E, Remick RA, Sadovnick AD, McElroy SL, Keck PE Jr, Schork NJ, Kelsoe JR. 2006. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet Part B 141B(3): 234241.
  • Novak G, Seeman P, Tallerico T. 2006. Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse 59(1): 6168.
  • Numata S, Iga J, Nakataki M, Tayoshi S, Taniguchi K, Sumitani S, Tomotake M, Tanahashi T, Itakura M, Kamegaya Y, et al. 2009. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. Am J Med Genet Part B 150B(4): 527534.
  • Nunes PV, Forlenza OV, Gattaz WF. 2007. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry 190: 359360.
  • O'Donovan MC, Craddock NJ, Owen MJ. 2009. Genetics of psychosis; insights from views across the genome. Hum Genet 126(1): 312.
  • Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB. 2004. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: An expanded convergent functional genomics approach. Mol Psychiatry 9(11): 10071029.
  • Oh ES, Savonenko AV, King JF, Fangmark Tucker SM, Rudow GL, Xu G, Borchelt DR, Troncoso JC. 2008. Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol Aging. 30(8): 12381244.
  • Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA. 2008. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65(4): 395407.
  • Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B, Nee J, Grunn A, Kanyas K, Lerer B, et al. 2004. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol Psychiatry 9(12): 10911099.
  • Parlapani E, Schmitt A, Erdmann A, Bernstein HG, Breunig B, Gruber O, Petroianu G, von Wilmsdorff M, Schneider-Axmann T, Honer W, et al. 2009. Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia. Brain Res.
  • Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, Aron L, Rietschel M, Wellek S, Soronen P, et al. 2007. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 39(3): 229238.
  • Paynter NP, Chasman DI, Pare G, Buring JE, Cook NR, Miletich JP, Ridker PM. 2010. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 303(7): 631637.
  • Pennington K, Beasley CL, Dicker P, Fagan A, English J, Pariante CM, Wait R, Dunn MJ, Cotter DR. 2008. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry. 13(12): 11021117.
  • Perlis RH, Purcell S, Fagerness J, Kirby A, Petryshen TL, Fan J, Sklar P. 2008. Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry 65(1): 5361.
  • Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 2008. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry 13(7): 654, 709–716.
  • Pillai A. 2008. Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: A correlation with BDNF expression. PLoS ONE 3(3): e1784.
  • Pletnikov MV, Xu Y, Ovanesov MV, Kamiya A, Sawa A, Ross CA. 2007. PC12 cell model of inducible expression of mutant DISC1: New evidence for a dominant-negative mechanism of abnormal neuronal differentiation. Neurosci Res 58(3): 234244.
  • Potash JB, Zandi PP, Willour VL, Lan TH, Huo Y, Avramopoulos D, Shugart YY, MacKinnon DF, Simpson SG, McMahon FJ, et al. 2003. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 160(4): 680686.
  • Potash JB, Buervenich S, Cox NJ, Zandi PP, Akula N, Steele J, Rathe JA, Avramopoulos D, Detera-Wadleigh SD, Gershon ES, et al. 2008. Gene-based SNP mapping of a psychotic bipolar affective disorder linkage region on 22q12.3: Association with HMG2L1 and TOM1. Am J Med Genet Part B 147B(1): 5967.
  • Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256): 748752.
  • Radhakrishna U, Senol S, Herken H, Gucuyener K, Gehrig C, Blouin JL, Akarsu NA, Antonarakis SE. 2001. An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2-q11.2 in a large Turkish pedigree. Eur J Hum Genet 9(1): 3944.
  • Ranade SS, Mansour H, Wood J, Chowdari KV, Brar LK, Kupfer DJ, Nimgaonkar VL. 2003. Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder. Am J Med Genet Part B 121B(1): 2834.
  • Rice TK, Schork NJ, Rao DC. 2008. Methods for handling multiple testing. Adv Genet 60: 293308.
  • Ripperger JA, Schibler U. 2006. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet 38(3): 369374.
  • Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E, Jerome RE, Lumeng L, Nurnberger JI Jr, Edenberg HJ, et al. 2007. Candidate genes, pathways and mechanisms for alcoholism: An expanded convergent functional genomics approach. Pharmacogenomics J 7(4): 222256.
  • Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie LA, Head E. 2008. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 28(12): 30513059.
  • Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. 2006. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11(10): 965978.
  • Sawamura N, Sawamura-Yamamoto T, Ozeki Y, Ross CA, Sawa A. 2005. A form of DISC1 enriched in nucleus: Altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc Natl Acad Sci USA 102(4): 11871192.
  • Schosser A, Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Craddock N, Farmer A, Korszun A, Gunasinghe C, Gray J, et al. 2009. Association of DISC1 and TSNAX genes and affective disorders in the depression case-control (DeCC) and bipolar affective case-control (BACCS) studies. Mol Psychiatry. [Epub ahead of print]
  • Schulze TG, Chen YS, Badner JA, McInnis MG, DePaulo JR Jr, McMahon FJ. 2003. Additional, physically ordered markers increase linkage signal for bipolar disorder on chromosome 18q22. Biol Psychiatry 53(3): 239243.
  • Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J, Pearl J, Strohmaier J, Breuer R, Schwarz M, et al. 2009. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14(5): 487491.
  • Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, Craddock N, DePaulo JR, Baron M, Gershon ES, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 73(1): 4962.
  • Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry
  • Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA, Turecki G. 2007. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 12(7): 640655.
  • Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, McMahon FJ, Gershon ES, Liu C. 2008. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet. 147B(7): 10471055.
  • Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7(6): 579593.
  • Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C, Macedo A, Dourado A, Coelho I, Valente J, et al. 2004. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 9(2): 213218.
  • Sklar P, Smoller JW, Fan J, Ferreira MAR, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, et al. 2008. Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6): 558569.
  • Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, Byerley W, Coryell W, Craig D, Edenberg HJ, et al. 2009. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14(8): 755763.
  • Sokolov BP, Polesskaya OO, Uhl GR. 2003. Mouse brain gene expression changes after acute and chronic amphetamine. J Neurochem 84(2): 244252.
  • Stumpf MP, Thorne T, de Silva E, Stewart R, An HJ, Lappe M, Wiuf C. 2008. Estimating the size of the human interactome. Proc Natl Acad Sci USA 105(19): 69596964.
  • Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ. 2008. Amyloid-associated depression: A prodromal depression of Alzheimer disease? Arch Gen Psychiatry 65(5): 542550.
  • Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M, Czerski PM, Hauser J. 2006. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 7(3): 158161.
  • Takahashi JS, Shimomura K, Kumar V. 2008. Searching for genes underlying behavior: Lessons from circadian rhythms. Science 322(5903): 909912.
  • Tan HY, Callicott JH, Weinberger DR. 2008. Intermediate phenotypes in schizophrenia genetics redux: Is it a no brainer? Mol Psychiatry 13(3): 233238.
  • Thomson PA, Wray NR, Millar JK, Evans KL, Hellard SL, Condie A, Muir WJ, Blackwood DH, Porteous DJ. 2005. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 10(7): 657668, 616.
  • Thomson PA, Christoforou A, Morris SW, Adie E, Pickard BS, Porteous DJ, Muir WJ, Blackwood DH, Evans KL. 2007. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 12(1): 94104.
  • Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362(9386): 798805.
  • Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. 2008. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 60(2): 184191.
  • Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. 2005. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57(3): 252260.
  • Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, et al. 2009. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J
  • van der Veen DR, Minh NL, Gos P, Arneric M, Gerkema MP, Schibler U. 2006. Impact of behavior on central and peripheral circadian clocks in the common vole Microtus arvalis, a mammal with ultradian rhythms. Proc Natl Acad Sci USA 103(9): 33933398.
  • van West D, Van Den Eede F, Del-Favero J, Souery D, Norrback KF, Van Duijn C, Sluijs S, Adolfsson R, Mendlewicz J, Deboutte D, et al. 2006. Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression. Neuropsychopharmacology 31(3): 620627.
  • Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ. 2002. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7(6): 571578.
  • Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, Choudary P, Atz M, Shao L, Neal C, et al. 2006. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders. Mol Psychiatry
  • Wager-Smith K, Kay SA. 2000. Circadian rhythm genetics: From flies to mice to humans. Nat Genet 26(1): 2327.
  • Wakabayashi Y, Uchida S, Funato H, Matsubara T, Watanuki T, Otsuki K, Fujimoto M, Nishida A, Watanabe Y. 2008. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 32(5): 11991205.
  • Walss-Bass C, Raventos H, Montero AP, Armas R, Dassori A, Contreras S, Liu W, Medina R, Levinson DF, Pereira M, et al. 2006. Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population. Acta Psychiatr Scand 113(4): 314321.
  • Wirz-Justice A. 2006. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 21 (Suppl. 1): S11S15.
  • Wirz-Justice A, Terman M, Oren DA, Goodwin FK, Kripke DF, Whybrow PC, Wisner KL, Wu JC, Lam RW, Berger M, et al. 2004. Brightening depression. Science 303(5657): 467469.
  • Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M, Cantor RM, McCann SM, Licinio J. 2006. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci USA 103(41): 1512415129.
  • Wong ML, Dong C, Maestre-Mesa J, Licinio J. 2008. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 13(8): 800812.
  • WTCC. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145): 661678.
  • Xing G, Russell S, Hough C, O'Grady J, Zhang L, Yang S, Zhang LX, Post R. 2002. Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport 13(4): 501505.
  • Yang S, Van Dongen HP, Wang K, Berrettini W, Bucan M. 2008. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry
  • Zamvil S, Nelson P, Trotter J, Mitchell D, Knobler R, Fritz R, Steinman L. 1985. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317(6035): 355358.
  • Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, Liu X, Atwood A, Huss JW III, Janes J, et al. 2009. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 139(1): 199210.
  • Zubenko GS, Hughes HB, Stiffler JS, Zubenko WN, Kaplan BB. 2002. Genome survey for susceptibility loci for recurrent, early-onset major depression: Results at 10cM resolution. Am J Med Genet 114(4): 413422.
  • Zubenko GS, Maher B, Hughes HB III, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML. 2003. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet Part B 123B(1): 118.